RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection.

Hepatology · 2020 · PMC7496196 · PMID 31654573

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP < 0.0001actually significant

The high‐dose ARC‐520 group showed a highly significant reduction in HBsAg ( P < 0.0001) compared to placebo, with a mean reduction of 0.379 log IU/mL from baseline (Fig. 1 B).

also in 132,142 other papers

did not reach statistical significanceno p-value reported

The low‐dose groups did not reach statistical significance in either study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.